These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21912666)

  • 21. Characterization of human single-chain antibodies against highly pathogenic avian influenza H5N1 viruses: mimotope and neutralizing activity.
    Yang J; Yoshida R; Kariya Y; Zhang X; Hashiguchi S; Nakashima T; Suda Y; Takada A; Ito Y; Sugimura K
    J Biochem; 2010 Oct; 148(4):507-15. PubMed ID: 20675684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of cross-clade monoclonal antibodies against H5N1 highly pathogenic avian influenza virus and their application to the antigenic analysis of diverse H5 subtype viruses.
    Gronsang D; Bui AN; Trinh DQ; Bui VN; Nguyen KV; Can MX; Omatsu T; Mizutani T; Nagai M; Katayama Y; Thampaisarn R; Ogawa H; Imai K
    Arch Virol; 2017 Aug; 162(8):2257-2269. PubMed ID: 28405766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humanized antibodies with broad-spectrum neutralization to avian influenza virus H5N1.
    Chen Y; Luo W; Wu WL; Fang Z; Xia L; Gui X; Chen Y; Chen H; Shih JW; Xia N
    Antiviral Res; 2010 Jul; 87(1):81-4. PubMed ID: 20450935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epitope mapping of neutralizing monoclonal antibody in avian influenza A H5N1 virus hemagglutinin.
    Ohkura T; Kikuchi Y; Kono N; Itamura S; Komase K; Momose F; Morikawa Y
    Biochem Biophys Res Commun; 2012 Feb; 418(1):38-43. PubMed ID: 22226969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and structural characterization of a broadly neutralizing antibody targeting a novel conserved epitope on the influenza virus H5N1 hemagglutinin.
    Du L; Jin L; Zhao G; Sun S; Li J; Yu H; Li Y; Zheng BJ; Liddington RC; Zhou Y; Jiang S
    J Virol; 2013 Feb; 87(4):2215-25. PubMed ID: 23221567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The antigenic architecture of the hemagglutinin of influenza H5N1 viruses.
    Velkov T; Ong C; Baker MA; Kim H; Li J; Nation RL; Huang JX; Cooper MA; Rockman S
    Mol Immunol; 2013 Dec; 56(4):705-19. PubMed ID: 23933511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.
    Throsby M; van den Brink E; Jongeneelen M; Poon LL; Alard P; Cornelissen L; Bakker A; Cox F; van Deventer E; Guan Y; Cinatl J; ter Meulen J; Lasters I; Carsetti R; Peiris M; de Kruif J; Goudsmit J
    PLoS One; 2008; 3(12):e3942. PubMed ID: 19079604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of antibody response to an epitope in the haemagglutinin subunit 2 of avian influenza virus H5N1 for differentiation of infected and vaccinated chickens.
    Putri K; Wibowo MH; Tarigan S; Wawegama N; Ignjatovic J; Noormohammadi AH
    Avian Pathol; 2020 Apr; 49(2):161-170. PubMed ID: 31738584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules.
    Hultberg A; Temperton NJ; Rosseels V; Koenders M; Gonzalez-Pajuelo M; Schepens B; Ibañez LI; Vanlandschoot P; Schillemans J; Saunders M; Weiss RA; Saelens X; Melero JA; Verrips CT; Van Gucht S; de Haard HJ
    PLoS One; 2011 Apr; 6(4):e17665. PubMed ID: 21483777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human 4F5 single-chain Fv antibody recognizing a conserved HA1 epitope has broad neutralizing potency against H5N1 influenza A viruses of different clades.
    Zhang X; Qi X; Zhang Q; Zeng X; Shi Z; Jin Q; Zhan F; Xu Y; Liu Z; Feng Z; Jiao Y
    Antiviral Res; 2013 Aug; 99(2):91-9. PubMed ID: 23680121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of monoclonal antibodies reactive against subtype specific conserved B-cell epitopes on haemagglutinin protein of influenza virus H5N1.
    Fiebig P; Shehata AA; Liebert UG
    Virus Res; 2015 Mar; 199():46-55. PubMed ID: 25599601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of H5 avian influenza viruses by antigen-capture enzyme-linked immunosorbent assay using H5-specific monoclonal antibody.
    He Q; Velumani S; Du Q; Lim CW; Ng FK; Donis R; Kwang J
    Clin Vaccine Immunol; 2007 May; 14(5):617-23. PubMed ID: 17344345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets.
    Khurana S; Suguitan AL; Rivera Y; Simmons CP; Lanzavecchia A; Sallusto F; Manischewitz J; King LR; Subbarao K; Golding H
    PLoS Med; 2009 Apr; 6(4):e1000049. PubMed ID: 19381279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies.
    Wang W; Song HS; Keller PW; Alvarado-Facundo E; Vassell R; Weiss CD
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying conserved DR1501-restricted CD4(+) T-cell epitopes in avian H5N1 hemagglutinin proteins.
    Wang SF; Yao L; Liu SJ; Chong P; Liu WT; Chen YM; Huang JC
    Viral Immunol; 2010 Dec; 23(6):585-93. PubMed ID: 21142444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.
    Khurana S; Chearwae W; Castellino F; Manischewitz J; King LR; Honorkiewicz A; Rock MT; Edwards KM; Del Giudice G; Rappuoli R; Golding H
    Sci Transl Med; 2010 Jan; 2(15):15ra5. PubMed ID: 20371470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of monoclonal antibodies to highly pathogenic avian influenza H5N1 virus and their application to diagnostics, prophylaxis, and therapy.
    Masalova OV; Klimova RR; Chichev EV; Fediakina IT; Loginova SY; Borisevich SV; Bondarev VP; Deryabin PG; Lvov DK; Kushch AA
    Acta Virol; 2011; 55(1):3-14. PubMed ID: 21434700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the M2e antibody response following highly pathogenic H5N1 avian influenza virus infection and reliability of M2e ELISA for identifying infected among vaccinated chickens.
    Tarigan S; Indriani R; Durr PA; Ignjatovic J
    Avian Pathol; 2015; 44(4):259-68. PubMed ID: 25915110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human monoclonal ScFv that bind to different functional domains of M2 and inhibit H5N1 influenza virus replication.
    Pissawong T; Maneewatch S; Thueng-In K; Srimanote P; Dong-din-on F; Thanongsaksrikul J; Songserm T; Tongtawe P; Bangphoomi K; Chaicumpa W
    Virol J; 2013 May; 10():148. PubMed ID: 23672256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A live attenuated H5N2 prime- inactivated H5N1 boost vaccination induces influenza virus hemagglutinin stalk specific antibody responses.
    Kongchanagul A; Samnuan K; Wirachwong P; Surichan S; Puthavathana P; Pitisuttithum P; Boonnak K
    Vaccine; 2020 Jan; 38(4):852-858. PubMed ID: 31708176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.